|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.91 USD | -0.37% |
|
+0.59% | +99.26% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 91.68M 79.51M 74.19M 68.17M 129M 8.74B 130M 872M 341M 4.36B 344M 337M 14.46B | P/E 2026 * |
1.15x | P/E 2027 * | -5.52x |
|---|---|---|---|---|---|
| Enterprise Value | 91.68M 79.51M 74.19M 68.17M 129M 8.74B 130M 872M 341M 4.36B 344M 337M 14.46B | EV / Sales 2026 * |
1.15x | EV / Sales 2027 * | 0.75x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | -0.37% | ||
| 1 week | +0.59% | ||
| Current month | +0.16% | ||
| 1 month | -7.35% | ||
| 3 months | +31.78% | ||
| 6 months | +55.89% | ||
| Current year | +99.26% |
| 1 week | 18.7 |  | 19.08 |
| 1 month | 17.9 | | 20.35 |
| Current year | 9.49 | | 21.43 |
| 1 year | 6.27 | | 21.43 |
| 3 years | 4.72 | | 21.43 |
| 5 years | 4.72 | | 26.6 |
| 10 years | 0 | | 26.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 2013-12-19 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 2012-02-21 |
David Jin
DFI | Director of Finance/CFO | 36 | 2022-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 2008-11-30 |
| Chairman | 71 | 2013-12-19 | |
J. Jay Lobell
BRD | Director/Board Member | 63 | 2006-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.37% | +0.59% | - | - | 91.68M | |
| +0.19% | +14.01% | +36.11% | -1.40% | 75.81B | |
| +0.86% | -9.15% | +20.80% | +181.80% | 48.57B | |
| +3.72% | -4.47% | -7.16% | +18.96% | 46.01B | |
| +3.64% | +10.69% | -51.21% | -51.75% | 41.66B | |
| +3.29% | +4.15% | +57.98% | -22.15% | 29.82B | |
| +1.83% | +1.46% | +59.54% | +85.60% | 24.01B | |
| +3.36% | +2.44% | +106.45% | -48.17% | 22.01B | |
| +0.81% | -2.97% | -6.77% | +164.33% | 19.09B | |
| +0.05% | -5.99% | +64.98% | +113.20% | 15.83B | |
| Average | +1.47% | +0.03% | +31.19% | +48.94% | 35.87B | |
| Weighted average by Cap. | +1.71% | +2.07% | +23.81% | +39.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.27M 64.63M 59.39M 112M 7.62B 113M 760M 297M 3.8B 300M 293M 12.6B | 123M 107M 99.53M 91.45M 173M 11.73B 175M 1.17B 458M 5.85B 462M 452M 19.4B |
| Net income | 90.51M 78.49M 73.24M 67.3M 127M 8.63B 128M 861M 337M 4.3B 340M 332M 14.27B | -20.84M -18.07M -16.86M -15.49M -29.31M -1.99B -29.57M -198M -77.58M -991M -78.26M -76.54M -3.29B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$18.91 | -0.37% | 15,714 |
| 26-08-03 | US$18.98 | +0.53% | 19,962 |
| 26-07-31 | US$18.88 | +0.43% | 3,917 |
| 26-07-30 | US$18.80 | -0.05% | 27,555 |
| 26-07-29 | US$18.81 | +0.27% | 10,182 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
Select your edition
All financial news and data tailored to specific country editions
